Electromedical Technologies, Inc (EMED)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

5 annual periodsNewest to oldest
20232022202120202019
Revenue$1.3M$1.1M$907,362$737,958$829,737
Gross profit$1.0M$888,641$708,128$543,574$591,221
Research & development$231,434$92,299$215,320$31,600$82,849
Operating income−$2.1M−$1.6M−$3.8M−$3.2M−$1.7M
EBITDAderived−$2.1M−$1.6M−$3.8M−$3.1M−$1.6M
Net income−$2.6M−$3.5M−$8.5M−$3.9M−$1.7M
Basic EPSper diluted share$0.00-$0.03-$0.24-$0.20-$0.10
Diluted EPSper diluted share$0.00-$0.03-$0.24-$0.20-$0.10

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.